Diabetes mellitus (DM) is accompanied by a series of macrovascular and microvascular injuries. Critical limb ischemia is the most severe manifestation of peripheral artery disease (PAD) caused by DM and is almost incurable. Therapeutic modulation of angiogenesis holds promise for the prevention of limb ischemia in diabetic patients with PAD. However, no small-molecule drugs are capable of promoting diabetic angiogenesis. An endogenous tryptophan metabolite, indole-3-aldehyde (3-IAld), has been found to have proangiogenic activity in endothelial cells. Nevertheless, the role of 3-IAld in diabetic angiogenesis remains unknown. Here, we found that 3-IAld ameliorated high glucose-induced mitochondrial dysfunction, decreasing oxidative stress and apoptosis and thus improving neovascularization.
A Tryptophan Metabolite of the Microbiota Improves Neovascularization in Diabetic Limb Ischemia
Xiurui Ma,Jinjing Yang,Guanrui Yang,Lei Li,Xiao-Rui Hao,Guoqing Wang,J. An,Fei Wang
Published 2022 in Frontiers in Cardiovascular Medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Frontiers in Cardiovascular Medicine
- Publication date
2022-06-02
- Fields of study
Biology, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-40 of 40 references · Page 1 of 1
CITED BY
Showing 1-14 of 14 citing papers · Page 1 of 1